Three FDA representatives discuss new drug indications, safety precautions and label changes, & an emergency program to rapidly evaluate existing immunomodulating therapies for use in COVID-19 patients.
Search results for: pediatric rheumatology
Advantages of Embedding a Specialty Pharmacist in a Rheumatology Clinic
The number of medications with rheumatologic indications has increased in parallel with expanding complexities of medication approval and delivery. Simply starting a patient on a biologic medication or new disease-modifying anti-rheumatic drug (DMARD) can be time consuming and frustrating for physicians, nurses and their support staff. In addition to educating the patient and obtaining prior…
Advancing Rheumatology Care Through State & Local Societies
As his term as chair of the Affiliate Society Council draws to a close, Chris Adams, MD, FACP, FACR, reflects on the personal and professional rewards of volunteer leadership and the importance and impact of coordinated state-level advocacy efforts for the future of rheumatology.
Fall 2020’s Awards, Appointments & Announcements in Rheumatology
S. Louis Bridges Jr., MD, PhD, Moves to New York S. Louis Bridges Jr., MD, PhD, became the new physician in chief and chair of the Department of Medicine, Hospital for Special Surgery (HSS), New York, on Sept. 1. He will also serve as the chief of rheumatology at Weill Cornell College of Medicine. Prior…
The History of the American College of Rheumatology Image Library
Late-night gatherings; long hours of avid discussion weighing the merits of resolution quality, light, hues and tones; and camaraderie among members forged through a shared interest in maintaining the highest fidelity to their craft and profession—these are among the vivid memories of those who participated in the early years of building what is today known…
RheumPAC Supports Rheumatology Through the Pandemic
With usual in-person fundraisers and meetings not possible during the pandemic, RheumPAC is finding creative ways to keep advocating for influential legislation and ensure rheumatology’s voice is heard in Washington, D.C.
The ACR Is Helping Rheumatology Practices Meet COVID-19 Challenges
These are difficult times for rheumatologists. We have seen sharp declines in face-to-face patient visits since the COVID‑19 pandemic began. Many of us have questions about the best ways to maintain employee and patient safety while keeping our practices afloat and continuing to provide optimal care. The volunteer leaders at the ACR continue to care…
ACR Releases COVID-19 Clinical Guidance for Pediatric Patients with Rheumatic Disease
The recommendations for pediatric rheumatology patients address various treatment options and provide general guidance, as well as direction for when to start, stop or reduce medications.
Caring for Pediatric Patients During a Pandemic: Q&A with Jay Mehta, MD
Caring for pediatric patients during a pandemicin the age of COVID-19 requires adaptations, says Jay Mehta, MD, Children’s Hospital of Philadelphia. “The one exposure that seems to put [pediatric] patients at risk is if they are on higher doses of steroids, with some data suggesting worse outcomes. We just put out guidelines telling providers to reduce steroids in their patients to the lowest dose that can adequately control their disease.”
Florida Society of Rheumatology in the Spotlight
Advocacy efforts on access and workforce issues in Florida are discussed.
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 90
- Next Page »